Evidence map›Paper›PMID 28585053›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2017

Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.

J Coulson, L Bagley, Y Barnouin, S Bradburn, G Butler-Browne, H Gapeyeva, J-Y Hogrel, T Maden-Wilkinson, A B Maier, C Meskers and 9 more

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Clinical Data for Parametrization ofFrontiers in bioengineering and biotechnology · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Serum sclerostin levels in osteoporotic fracture patients.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 7 countries.

J CoulsonSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
L BagleySchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
Y BarnouinSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
S BradburnSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
G Butler-BrowneInstitut de Myologie, GH Pitié-Salpêtrière, Paris, France.
H GapeyevaInstitute of Sport Sciences and Physiotherapy, University of Tartu, Tartu, Estonia.
J-Y HogrelInstitut de Myologie, GH Pitié-Salpêtrière, Paris, France.
T Maden-WilkinsonSchool of Physical Activity and Health, Sheffield Hallam University, Sheffield, UK.
A B MaierDepartment of Human Movement Sciences, MOVE Research Institute, Vrij University, Amsterdam, The Netherlands.
C MeskersRehabilitation Medicine, VU University Medical Center, Amsterdam, The Netherlands.
C MurgatroydSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
M NariciGraduate Entry Medicine and Health, University of Nottingham, Nottingham, UK.
M PääsukeInstitute of Sport Sciences and Physiotherapy, University of Tartu, Tartu, Estonia.
L SassanoUnilever Discover, Colworth Park, Sharnbrook, Bedford, UK.
S SipiläGerontology Research Center, Department of Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
N Al-ShantiSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
L StenrothGerontology Research Center, Department of Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
D A JonesSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK.
J S McPheeSchool of Healthcare Science, Manchester Metropolitan University, John Dalton Building, Chester Street, Manchester, M15GD, UK. J.s.mcphee@mmu.ac.uk.
Manchester Metropolitan University · GBSorbonne Université · FRUniversity of Tartu · EEAmsterdam UMC Location VUmc · NLBaylor College of Medicine · USSheffield Hallam University · GBUnilever (United Kingdom) · GBUniversity of Eastern Finland · FIUniversity of Jyväskylä · FIUniversity of Melbourne · AUUniversity of Nottingham · GB

Funding

European Union FP7 MYOAGE 223576Medical Research Council MR/K025252/1
6 · The paper itself

Abstract

Bone mineral density declines with increasing older age. We examined the levels of circulating factors known to regulate bone metabolism in healthy young and older adults. The circulating levels of dickkopf-1, osteocalcin, osteoprotegerin and sclerostin were positively associated with whole-body bone mineral density (WBMD) in older adults, despite the average WBMD being lower and circulating dickkopf-1, osteoprotegerin and sclerostin being higher in old than young.

introductionThis study aims to investigate the relationship between whole-body bone mineral density (WBMD) and levels of circulating factors with known roles in bone remodelling during 'healthy' ageing.

methodsWBMD and fasting plasma concentrations of dickkopf-1, fibroblast growth factor-23, osteocalcin, osteoprotegerin, osteopontin and sclerostin were measured in 272 older subjects (69 to 81 years; 52% female) and 171 younger subjects (18-30 years; 53% female).

resultsWBMD was lower in old than young. Circulating osteocalcin was lower in old compared with young, while dickkopf-1, osteoprotegerin and sclerostin were higher in old compared with young. These circulating factors were each positively associated with WBMD in the older adults and the relationships remained after adjustment for covariates (r values ranging from 0.174 to 0.254, all p < 0.01). In multivariate regression, the body mass index, circulating sclerostin and whole-body lean mass together accounted for 13.8% of the variation with WBMD in the older adults. In young adults, dickkopf-1 and body mass index together accounted for 7.7% of variation in WBMD.

conclusionCirculating levels of dickkopf-1, osteocalcin, osteoprotegerin and sclerostin are positively associated with WBMD in community-dwelling older adults, despite the average WBMD being lower and circulating dickkopf-1, osteoprotegerin and sclerostin being higher in old than young.

Indexed as

Absorptiometry, PhotonAdaptor Proteins, Signal TransducingAdolescentAdultAgedAged, 80 and overAgingBiomarkersBody Mass IndexBone DensityBone Morphogenetic ProteinsBone RemodelingBone ResorptionCross-Sectional StudiesEuropeFemaleAdaptor Proteins, Signal TransducingBiomarkersBone Morphogenetic ProteinsDKK1 protein, humanGenetic MarkersIntercellular Signaling Peptides and ProteinsOsteoprotegerinSOST protein, humanTNFRSF11B protein, humanDKK1MYOAGEOsteoporosisOsteoprotegerinSclerostin

Identifiers

PMID28585053
OpenAlexW2623035632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.